Inventor · disambiguated record
Wayne W. Hancock
Also filed as: HANCOCK WAYNE · HANCOCK WAYNE W · HANCOCK WAYNE WILLIAM
8 granted patents·10 pending applications·151 citations·filing 2001–2022
88Inventor score
Files withMILLENNIUM PHARM INC5SANOFI AVENTIS DEUTSCHLAND2AUM LIFETECH INC1AVENTIS PHARMA GMBH1CHILDRENS HOSPITAL PHILADELPHIA1
Top patents by PatentIndex Score
18 records- 0193US6534277B1Method for identifying a compound to be tested for an ability to reduce immune rejection by determining Stat4 and Stat6 proteinsMILLENNIUM PHARM INC·Filed 2001·Granted Mar 18, 2003·40 cites·9 claims
- 0292US9249087B2HDAC inhibitors and therapeutic methods using the sameKOZIKOWSKI ALAN·Filed 2012·Granted Feb 2, 2016·46 cites·14 claims
- 0390US9717717B1Methods of treating cancer through the inhibition of USP7 and immune system modulationPROGENRA INC·Filed 2016·Granted Aug 1, 2017·9 cites·18 claims
- 0489US6627637B2Substituted beta carbolinesAVENTIS PHARMA GMBH·Filed 2001·Granted Sep 30, 2003·38 cites·38 claims
- 0585US7348336B2Substituted β-carbolinesSANOFI AVENTIS DEUTSCHLAND·Filed 2006·Granted Mar 25, 2008·6 cites·22 claims
- 0677USRE47009EHDAC inhibitors and therapeutic methods using the sameCHILDRENS HOSPITAL PHILADELPHIA·Filed 2012·Granted Aug 28, 2018·4 cites·14 claims
- 0776US7026331B2Substituted beta-carbolinesSANOFI AVENTIS DEUTSCHLAND·Filed 2003·Granted Apr 11, 2006·7 cites·22 claims
- 0870US8497285B2Therapy of autoimmune colitis using a TIP60 inhibitorGREENE MARK I·Filed 2011·Granted Jul 30, 2013·1 cites·20 claims
- 0961US2024041981A1Methods of using interleukin-2 agentsVISTERRA INC·Filed 2022·Application pending·0 cites
- 1056US2010061984A1Compositions and methods for modulation of suppressor t cell activationUNIV PENNSYLVANIA·Filed 2007·Application pending·0 cites
- 1150US2003215442A1Methods and compositions for the treatment or prevention of immune disorders using combination therapyFiled 2003·Application pending·0 cites
- 1249US2010310635A1Compositions and Methods for Regulating T-Cell ActivityOZKAYNAK ENGIN·Filed 2008·Application pending·0 cites
- 1346US2002160947A1Synergistic method for prolonging allograft survivalMILLENNIUM PHARM INC·Filed 2002·Application pending·0 cites
- 1445US2002019345A1Method of treating graft rejection using inhibitors of CCR5 functionMILLENNIUM PHARM INC·Filed 2001·Application pending·0 cites
- 1545US2021340536A12' fana modified foxp3 antisense oligonucleotides and methods of use thereofAUM LIFETECH INC·Filed 2019·Application pending·0 cites
- 1643US2002042370A1Method of treating graft rejection using inhibitors of CCR2 functionMILLENNIUM PHARM INC·Filed 2001·Application pending·0 cites
- 1741US2013323283A1Compositions and methods for treating foxp3+ treg related diseasesHANCOCK WAYNE W·Filed 2011·Application pending·0 cites
- 1840US2002018776A1Method of treating graft rejection using inhibitors of CXCR3 functionMILLENNIUM PHARM INC·Filed 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Wayne W. Hancock files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →